Skip to main content
Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

IMMY20043/ HPN217 /Brea Lipe

Basic Study Information

Purpose:
An open-label, Phase 1/2 study of HPN217 as monotherapy to assess the safety, tolerability and PK in patients with relapsed/ refractory multiple myeloma

Location: University of Rochester James P Wilmot Cancer Institute

Lead Researcher (Principal Investigator)

Lead Researcher:  Brea Lipe

Study Contact Information

Study Coordinator: Lauren Mitchell
Email: lauren_mitchell@urmc.rochester.edu

Additional Study Details

Return to Search